Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001562180-18-003561

Options or other derivatives

  • President, Diagnostics & Genom acquired 22,768 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kelderman Kim President, Diagnostics & Genom 2018-08-08 Grant or award · Restricted Stock Units +1,691 1,691 D
Kelderman Kim President, Diagnostics & Genom 2018-08-08 Grant or award · Stock Options (Right to buy) +12,044 12,044 D
Kelderman Kim President, Diagnostics & Genom 2018-08-08 Grant or award · Stock Options (Right to buy) +9,033 9,033 D
Loading xslF345X03/primarydocument.xml…